Global Peptic Ulcer Drugs Competitive Landscape Professional Research Report 2025
Description
Global Peptic Ulcer Drugs Competitive Landscape Professional Research Report 2025
Research Summary
Peptic ulcer drugs, also known as ulcer medications or anti-ulcer drugs, are pharmaceutical agents designed to treat peptic ulcers, which are open sores that develop on the inner lining of the stomach, small intestine, or esophagus. These drugs aim to alleviate the symptoms of peptic ulcers, promote healing, and prevent further complications. Commonly used classes of peptic ulcer drugs include proton pump inhibitors (PPIs), H2 receptor antagonists, antacids, and cytoprotective agents. PPIs reduce the production of stomach acid by inhibiting the proton pumps in the stomach lining, while H2 receptor antagonists block the action of histamine, a chemical that triggers acid secretion. Antacids neutralize stomach acid, providing immediate relief from discomfort. Cytoprotective agents work to strengthen the protective mucous lining of the gastrointestinal tract. The choice of medication depends on the severity and cause of the ulcer, and treatment often involves a combination of these drugs, along with lifestyle modifications, to effectively manage and heal peptic ulcers.
According to DIResearch's in-depth investigation and research, the global Peptic Ulcer Drugs market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Peptic Ulcer Drugs include Takeda Pharmaceutical, AstraZeneca, Pfizer, Teva Pharmaceuticals, EA Pharma, ASK Pharm, Luoxin Pharmaceutical, Abbott Laboratories, Yuhan Pharmaceutical, Daewoong Pharmaceutical etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Peptic Ulcer Drugs. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Peptic Ulcer Drugs market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Peptic Ulcer Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peptic Ulcer Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Peptic Ulcer Drugs Include:
Takeda Pharmaceutical
AstraZeneca
Pfizer
Teva Pharmaceuticals
EA Pharma
ASK Pharm
Luoxin Pharmaceutical
Abbott Laboratories
Yuhan Pharmaceutical
Daewoong Pharmaceutical
Peptic Ulcer Drugs Product Segment Include:
Proton Pump Inhibitors
H2-Antagonists
Antacids
Others
Peptic Ulcer Drugs Product Application Include:
Hospital and Clinic
Drugstore
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Peptic Ulcer Drugs Industry PESTEL Analysis
Chapter 3: Global Peptic Ulcer Drugs Industry Porter’s Five Forces Analysis
Chapter 4: Global Peptic Ulcer Drugs Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Peptic Ulcer Drugs Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Peptic Ulcer Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Peptic Ulcer Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Peptic Ulcer Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Peptic Ulcer Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Peptic Ulcer Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Peptic Ulcer Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Peptic Ulcer Drugs Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Peptic Ulcer Drugs Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Peptic Ulcer Drugs Product by Type
- 1.2.1 Proton Pump Inhibitors
- 1.2.2 H2-Antagonists
- 1.2.3 Antacids
- 1.2.4 Others
- 1.3 Peptic Ulcer Drugs Product by Application
- 1.3.1 Hospital and Clinic
- 1.3.2 Drugstore
- 1.4 Global Peptic Ulcer Drugs Market Revenue and Sales Analysis
- 1.4.1 Global Peptic Ulcer Drugs Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Peptic Ulcer Drugs Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Peptic Ulcer Drugs Market Sales Price Trend Analysis (2020-2032)
- 1.5 Peptic Ulcer Drugs Industry Trends and Innovation
- 1.5.1 Peptic Ulcer Drugs Industry Trends and Innovation
- 1.5.2 Peptic Ulcer Drugs Market Drivers and Challenges
- 2 Peptic Ulcer Drugs Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Peptic Ulcer Drugs Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Peptic Ulcer Drugs Market Analysis by Regions
- 4.1 Peptic Ulcer Drugs Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Peptic Ulcer Drugs Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Peptic Ulcer Drugs Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Peptic Ulcer Drugs Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Peptic Ulcer Drugs Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Peptic Ulcer Drugs Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Peptic Ulcer Drugs Sales Forecast by Region (2026-2032)
- 4.4 Global Peptic Ulcer Drugs Sales Price Trend Analysis (2020-2032)
- 5 Global Peptic Ulcer Drugs Market Size by Type and Application
- 5.1 Global Peptic Ulcer Drugs Market Size by Type
- 5.1.1 Global Peptic Ulcer Drugs Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Peptic Ulcer Drugs Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Peptic Ulcer Drugs Market Size by Application
- 5.2.1 Global Peptic Ulcer Drugs Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Peptic Ulcer Drugs Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Peptic Ulcer Drugs Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Peptic Ulcer Drugs Market Size by Type
- 6.3.1 North America Peptic Ulcer Drugs Sales by Type (2020-2032)
- 6.3.2 North America Peptic Ulcer Drugs Revenue by Type (2020-2032)
- 6.4 North America Peptic Ulcer Drugs Market Size by Application
- 6.4.1 North America Peptic Ulcer Drugs Sales by Application (2020-2032)
- 6.4.2 North America Peptic Ulcer Drugs Revenue by Application (2020-2032)
- 6.5 North America Peptic Ulcer Drugs Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Peptic Ulcer Drugs Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Peptic Ulcer Drugs Market Size by Type
- 7.3.1 Europe Peptic Ulcer Drugs Sales by Type (2020-2032)
- 7.3.2 Europe Peptic Ulcer Drugs Revenue by Type (2020-2032)
- 7.4 Europe Peptic Ulcer Drugs Market Size by Application
- 7.4.1 Europe Peptic Ulcer Drugs Sales by Application (2020-2032)
- 7.4.2 Europe Peptic Ulcer Drugs Revenue by Application (2020-2032)
- 7.5 Europe Peptic Ulcer Drugs Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Peptic Ulcer Drugs Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Peptic Ulcer Drugs Market Size by Type
- 8.3.1 China Peptic Ulcer Drugs Sales by Type (2020-2032)
- 8.3.2 China Peptic Ulcer Drugs Revenue by Type (2020-2032)
- 8.4 China Peptic Ulcer Drugs Market Size by Application
- 8.4.1 China Peptic Ulcer Drugs Sales by Application (2020-2032)
- 8.4.2 China Peptic Ulcer Drugs Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Peptic Ulcer Drugs Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Peptic Ulcer Drugs Market Size by Type
- 9.3.1 APAC (excl. China) Peptic Ulcer Drugs Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Peptic Ulcer Drugs Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Peptic Ulcer Drugs Market Size by Application
- 9.4.1 APAC (excl. China) Peptic Ulcer Drugs Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Peptic Ulcer Drugs Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Peptic Ulcer Drugs Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Peptic Ulcer Drugs Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Peptic Ulcer Drugs Market Size by Type
- 10.3.1 Latin America Peptic Ulcer Drugs Sales by Type (2020-2032)
- 10.3.2 Latin America Peptic Ulcer Drugs Revenue by Type (2020-2032)
- 10.4 Latin America Peptic Ulcer Drugs Market Size by Application
- 10.4.1 Latin America Peptic Ulcer Drugs Sales by Application (2020-2032)
- 10.4.2 Latin America Peptic Ulcer Drugs Revenue by Application (2020-2032)
- 10.5 Latin America Peptic Ulcer Drugs Market Size by Country
- 10.6 Latin America Peptic Ulcer Drugs Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Peptic Ulcer Drugs Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Peptic Ulcer Drugs Market Size by Type
- 11.3.1 Middle East & Africa Peptic Ulcer Drugs Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Peptic Ulcer Drugs Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Peptic Ulcer Drugs Market Size by Application
- 11.4.1 Middle East & Africa Peptic Ulcer Drugs Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Peptic Ulcer Drugs Revenue by Application (2020-2032)
- 11.5 Middle East Peptic Ulcer Drugs Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Peptic Ulcer Drugs Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Peptic Ulcer Drugs Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Peptic Ulcer Drugs Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Peptic Ulcer Drugs Average Sales Price by Manufacturers (2021-2025)
- 12.2 Peptic Ulcer Drugs Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Peptic Ulcer Drugs Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Takeda Pharmaceutical
- 13.1.1 Takeda Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Takeda Pharmaceutical Peptic Ulcer Drugs Product Portfolio
- 13.1.3 Takeda Pharmaceutical Peptic Ulcer Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 AstraZeneca
- 13.2.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 AstraZeneca Peptic Ulcer Drugs Product Portfolio
- 13.2.3 AstraZeneca Peptic Ulcer Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Pfizer
- 13.3.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Pfizer Peptic Ulcer Drugs Product Portfolio
- 13.3.3 Pfizer Peptic Ulcer Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Teva Pharmaceuticals
- 13.4.1 Teva Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Teva Pharmaceuticals Peptic Ulcer Drugs Product Portfolio
- 13.4.3 Teva Pharmaceuticals Peptic Ulcer Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 EA Pharma
- 13.5.1 EA Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 EA Pharma Peptic Ulcer Drugs Product Portfolio
- 13.5.3 EA Pharma Peptic Ulcer Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 ASK Pharm
- 13.6.1 ASK Pharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 ASK Pharm Peptic Ulcer Drugs Product Portfolio
- 13.6.3 ASK Pharm Peptic Ulcer Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 Luoxin Pharmaceutical
- 13.7.1 Luoxin Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Luoxin Pharmaceutical Peptic Ulcer Drugs Product Portfolio
- 13.7.3 Luoxin Pharmaceutical Peptic Ulcer Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 Abbott Laboratories
- 13.8.1 Abbott Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Abbott Laboratories Peptic Ulcer Drugs Product Portfolio
- 13.8.3 Abbott Laboratories Peptic Ulcer Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 Yuhan Pharmaceutical
- 13.9.1 Yuhan Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Yuhan Pharmaceutical Peptic Ulcer Drugs Product Portfolio
- 13.9.3 Yuhan Pharmaceutical Peptic Ulcer Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.10 Daewoong Pharmaceutical
- 13.10.1 Daewoong Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Daewoong Pharmaceutical Peptic Ulcer Drugs Product Portfolio
- 13.10.3 Daewoong Pharmaceutical Peptic Ulcer Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Peptic Ulcer Drugs Industry Chain Analysis
- 14.2 Peptic Ulcer Drugs Industry Raw Material and Suppliers Analysis
- 14.2.1 Peptic Ulcer Drugs Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Peptic Ulcer Drugs Typical Downstream Customers
- 14.4 Peptic Ulcer Drugs Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
